혈액 처리 장치 및 소모품 시장 : 제품별, 최종사용자별, 지역별(2025-2033년)

The global blood processing devices and consumables market size reached USD 55.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 98.6 Billion by 2033, exhibiting a growth rate (CAGR) of 6.22% during 2025-2033. The rising demand for blood and its products, supportive policies by governmental and non-governmental organizations, and the recent development of a closed blood sampling system represent some of the key factors driving the market.

Blood processing devices and consumables refer to tools and materials used in the collection, processing, and transfusion of blood and its products. It includes tubes, bags, centrifuges, vials, freezers, filters, needles and syringes, blood culture systems, and plasma thawing devices. They are manufactured using various materials, such as plastic, glass, rubber, stainless steel, and titanium. Blood processing devices and consumables are widely used for blood storage, transport, separation, filtering, typing and cross-matching, irradiation, apheresis, and blood processing system. They enhance safety, increase efficiency, extend blood shelf-life, and minimize the risk of contamination, infections, and transfusion-related complications. Blood processing devices and consumables also aid in maintaining quality standards, reducing wastage, eliminating the need for manual sample handling, and ensuring the availability of blood and its products to healthcare facilities.

Blood Processing Devices and Consumables Market Trends:

The rising demand for blood and its various products, such as white blood cells (WBCs), red blood cells (RBCs), and plasma, due to increasing numbers of surgical procedures, is one of the primary factors propelling the market growth. Blood processing devices and consumables are widely used in healthcare facilities to collect, process, transport, and store blood products, as they ensure safety, improve clinical efficiency, enhance patient safety, maintain blood efficacy, and prevent contaminations. In addition to this, the growing number of blood-related disorders, such as sickle cell anemia and thalassemia, is acting as another growth-inducing factor. Furthermore, the implementation of supportive policies by governmental and non-governmental organizations to promote blood donation, educate the masses, and provide funding for blood collection and processing programs is positively influencing the market growth. Additionally, the recent development of a closed blood sampling system, which utilizes a needleless connection between the blood collection set and the blood bag to reduce the risk of infection, contamination, and needlestick injuries, is providing an impetus to the market growth. Besides this, the introduction of automated blood processing systems, which carry out multiple steps simultaneously, thus improving overall efficiency, reducing manual labor, minimizing operational costs, and saving time, is contributing to market growth. Moreover, the rising demand for point-of-care testing that allows healthcare professionals to perform blood tests and collect samples quickly at patients' homes is strengthening the market growth. Other factors, including the rapid expansion of the healthcare industry, increasing investments in the development of advanced devices, and the rising number of trauma cases, such as accidents, violence, and natural disaster, are anticipated to drive the market growth.

Key Market Segmentation:

Product Insights:

• Blood Processing Devices
• Blood Bank Freezers
• Blood Grouping Analyzers
• Blood Warmer
• Blood Cell Processers
• Others
• Blood Processing Consumables
• Blood Bags
• Blood Lancets
• Vials
• Blood Administration Sets
• Others

End User Insights:

• Hospitals and Clinics
• Diagnostic Laboratories
• Others

Regional Insights:

• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for blood processing devices and consumables. Some of the factors driving the North America blood processing devices and consumables market included rising demand for blood and its products, favorable government policies, and rapid technological advancements.

Competitive Landscape:

• The report has also provided a comprehensive analysis of the competitive landscape in the global blood processing devices and consumables market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, BioMerieux SA (Institut Merieux), Bio-Rad Laboratories Inc, Danaher Corporation, Grifols S.A., Haemonetics Corporation, Macopharma, Roche Holding AG, Terumo Corporation, Thermo Fisher Scientific Inc., ThermoGenesis Holdings, Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

• How has the global blood processing devices and consumables market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global blood processing devices and consumables market?
• What is the impact of each driver, restraint, and opportunity on the global blood processing devices and consumables market?
• What are the key regional markets?
• Which countries represent the most attractive blood processing devices and consumables market?
• What is the breakup of the market based on the product?
• Which is the most attractive product in the blood processing devices and consumables market?
• What is the breakup of the market based on the end user?
• Which is the most attractive end user in the blood processing devices and consumables market?
• What is the competitive structure of the global blood processing devices and consumables market?
• Who are the key players/companies in the global blood processing devices and consumables market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Blood Processing Devices and Consumables Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Blood Processing Devices
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Blood Bank Freezers
    • 6.1.2.2 Blood Grouping Analyzers
    • 6.1.2.3 Blood Warmer
    • 6.1.2.4 Blood Cell Processers
    • 6.1.2.5 Others
  • 6.1.3 Market Forecast
• 6.2 Blood Processing Consumables
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Blood Bags
    • 6.2.2.2 Blood Lancets
    • 6.2.2.3 Vials
    • 6.2.2.4 Blood Administration Sets
    • 6.2.2.5 Others
  • 6.2.3 Market Forecast

7 Market Breakup by End User

• 7.1 Hospitals and Clinics
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Diagnostic Laboratories
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

• 9.1 Overview
• 9.2 Drivers
• 9.3 Restraints
• 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Abbott Laboratories
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
    • 13.3.1.3 Financials
    • 13.3.1.4 SWOT Analysis
  • 13.3.2 BioMerieux SA (Institut Merieux)
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
    • 13.3.2.3 Financials
    • 13.3.2.4 SWOT Analysis
  • 13.3.3 Bio-Rad Laboratories Inc.
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
    • 13.3.3.3 Financials
    • 13.3.3.4 SWOT Analysis
  • 13.3.4 Danaher Corporation
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 Financials
    • 13.3.4.4 SWOT Analysis
  • 13.3.5 Grifols S.A.
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
    • 13.3.5.4 SWOT Analysis
  • 13.3.6 Haemonetics Corporation
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 Financials
    • 13.3.6.4 SWOT Analysis
  • 13.3.7 Macopharma
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
  • 13.3.8 Roche Holding AG
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
    • 13.3.8.3 Financials
  • 13.3.9 Terumo Corporation
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
    • 13.3.9.3 Financials
    • 13.3.9.4 SWOT Analysis
  • 13.3.10 Thermo Fisher Scientific Inc.
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio
    • 13.3.10.3 Financials
    • 13.3.10.4 SWOT Analysis
  • 13.3.11 ThermoGenesis Holdings, Inc.
    • 13.3.11.1 Company Overview
    • 13.3.11.2 Product Portfolio
    • 13.3.11.3 Financials
    • 13.3.11.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.